Elevated airway purines in COPD

Chest

Volumn 140, Issue 4, 2011, Pages 954-960

  Esther Jr , Charles R ^a   Lazaar, Aili L ^d   Bordonali, Elena ^b   Qaqish, Bahjat ^b   Boucher, Richard C ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; PHENYLALANINE; UREA;

ADULT; AIRWAY; ARTICLE; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NON INVASIVE MEASUREMENT; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; TISSUE LEVEL; UREA BLOOD LEVEL;

EID: 80053515728     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2471     Document Type: Article

References (35)

1. Spicuzza L, Di Maria G, Polosa R. Adenosine in the airways: implications and applications. Eur J Pharmacol. 2006;533(1-3):77-88. (Pubitemid 43340006)
2. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol. 1986;61(5):1667-1676. (Pubitemid 17196218)
3. Vizi E, Huszár E, Csoma Z, et al. Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol. 2002;109(3):446-448. (Pubitemid 34234194)
4. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fl uid in asthma. Am Rev Respir Dis. 1993;148(1):91-97. (Pubitemid 23187224)
5. Huszár E, Vass G, Vizi E, et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J. 2002;20(6):1393-1398. (Pubitemid 35469046)
6. Esther CR Jr, Boysen G, Olsen BM, et al. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fi brosis. Am J Physiol Lung Cell Mol Physiol. 2009; 296(6): L987-L993.
7. Csoma Z, Huszár E, Vizi E, et al. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J. 2005;25(5):873-878. (Pubitemid 40667686)
8. Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, Blackburn MR. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol. 2005;175(3):1937-1946. (Pubitemid 41023101)
9. Chunn JL, Young HW, Banerjee SK, Colasurdo GN, Blackburn MR. Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminasedeficient mice. J Immunol. 2001;167(8):4676-4685. (Pubitemid 32954349)
10. Mohsenin A, Blackburn MR. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2006;12(1):54-59. (Pubitemid 44378579)
11. Varani K, Caramori G, Vincenzi F, et al. Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(4):398-406. (Pubitemid 43228327)
12. Polosa R. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J. 2002;20(2):488-496.
13. Blackburn MR, Volmer JB, Thrasher JL, et al. Metabolic consequences of adenosine deaminase defi ciency in mice are asso ciated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med. 2000;192(2):159-170. (Pubitemid 30470299)
14. Versluis M, ten Hacken N, Postma D, et al. Adenosine receptors in COPD and asymptomatic smokers: effects of smoking cessation. Virchows Arch. 2009;454(3):273-281.
15. Esther CR Jr, Jasin HM, Collins LB, Swenberg JA, Boysen G. A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate. Rapid Commun Mass Spectrom. 2008;22(5):701-705. (Pubitemid 351373952)
16. Effros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med. 2003;168(12):1500-1505. (Pubitemid 38037336)
17. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientifi c Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276. (Pubitemid 32378468)
18. Sims MW, Tal-Singer RM, Kierstein S, et al. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res. 2008;9:13.
19. Vestbo J, Anderson W, Coxson HO, et al;ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008;31(4):869-873.
20. Lazarowski ER, Boucher RC, Harden TK. Constitutive release of ATP and evidence for major contribution of ectonucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem. 2000;275(40):31061-31068.
21. Esther CR Jr, Alexis NE, Clas ML, et al. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J. 2008;31(5):949-956.
22. Effros RM, Peterson B, Casaburi R, et al. Epithelial lining fl uid solute concentrations in chronic obstructive lung disease patients and normal subjects. J Appl Physiol. 2005;99(4): 1286-1292. (Pubitemid 43014331)
23. Vass G, Horváth I. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr Med Chem. 2008;15(9):917-922. (Pubitemid 351736412)
24. Livingston M, Heaney LG, Ennis M. Adenosine, inflammation and asthma-a review. Inflamm Res. 2004; 53 (5): 171-178.
25. Borrill ZL, Roy K, Singh D. Exhaled breath condensate biomarkers in COPD. Eur Respir J. 2008;32(2):472-486.
26. Lommatzsch M, Cicko S, Müller T, et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(9):928-934.
27. Lázár Z, Huszár É, Kullmann T, et al. Adenosine triphosphate in exhaled breath condensate of healthy subjects and patients with chronic obstructive pulmonary disease. Inflamm Res. 2008;57(8):367-373.
28. Alexis NE, Hu SC, Zeman K, Alter T, Bennett WD. Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med. 2001;164(10 pt 1):1964-1970. (Pubitemid 33152337)
29. Johnson GR, Morawska L. The mechanism of breath aerosol formation. J Aerosol Med Pulm Drug Deliv. 2009;22(3): 229-237.
30. Picher M, Burch LH, Boucher RC. Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fi brosis. J Biol Chem. 2004; 279 (19): 20234- 20241.
31. Effros RM, Hoagland KW, Bosbous M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med. 2002;165(5):663-669. (Pubitemid 34194754)
32. Horváth I, Hunt J, Barnes PJ, et alATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523-548. (Pubitemid 41264218)
33. Lazarowski ER, Tarran R, Grubb BR, Van Heusden CA, Okada S, Boucher RC. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem. 2004; 279(35):36855-36864. (Pubitemid 39129034)
34. Fredholm BB, Irenius E, Kull B, Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol. 2001;61(4):443-448. (Pubitemid 32168226)
35. Eltzschig HK, Weissmüller T, Mager A, Eckle T. Nucleotide metabolism and cell-cell interactions. Methods Mol Biol. 2006; 341:73-87.